ctrl K

Advertisement

RAPT Therapeutics Inc. (RAPT)

NASDAQ: RAPT · Real-Time Price · USD

0.91

-0.01 (-1.21%)

At close: Apr 29, 2025, 3:42 PM

RAPT Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	n/a	1.53M	3.81M	5.04M	n/a	n/a	n/a
Cost of Revenue	n/a	3.55M	2.81M	996K	n/a	1.33M	1.24M	1.38M
Gross Profit	n/a	-3.55M	-1.28M	2.82M	5.04M	-1.33M	-1.24M	-1.38M
Operating Income	-136.1M	-127.06M	-85.8M	-69.21M	-53.21M	-43.63M	-36.95M	-29.33M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-129.87M	-116.8M	-83.84M	-69.2M	-51.9M	-42.34M	-36.15M	-29.11M
Net Income	-129.87M	-116.8M	-81.88M	-68.21M	-52.89M	-43M	-36.15M	-29.11M
Selling & General & Admin	28.88M	26.06M	20.24M	16.04M	12.77M	8.72M	5.18M	3.71M
Research & Development	107.22M	101M	67.08M	56.98M	45.48M	34.91M	31.77M	25.62M
Other Expenses	n/a	n/a	1.96M	5K	1.31M	1.29M	800K	216K
Operating Expenses	136.1M	127.06M	87.32M	73.02M	58.26M	43.63M	36.95M	29.33M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	127.06M	87.32M	73.02M	58.26M	43.63M	36.95M	29.33M
Income Tax Expense	n/a	n/a	-1.96M	-996K	990K	660K	800K	n/a
Shares Outstanding (Basic)	40.76M	38.34M	32.54M	27.39M	24.13M	21.83M	17.33M	14.46M
Shares Outstanding (Diluted)	40.76M	38.34M	32.54M	27.39M	24.13M	21.83M	17.33M	14.46M
EPS (Basic)	-3.19	-3.05	-2.52	-2.49	-2.19	-1.97	-2.09	-2.01
EPS (Diluted)	-3.19	-3.05	-2.52	-2.49	-2.19	-1.97	-2.09	-2.01
EBITDA	-136.1M	-125.85M	-84.75M	-68.21M	-52.09M	-42.3M	-35.71M	-27.95M
EBIT	n/a	-127.06M	-85.8M	-69.21M	-53.21M	-43.63M	-36.95M	-29.33M
Depreciation & Amortization	n/a	1.22M	2.81M	996K	1.12M	1.33M	1.24M	1.38M